Actively Recruiting
Community-based Exercise Following Revascularization for PAD
Led by University of Minnesota · Updated on 2025-09-19
30
Participants Needed
1
Research Sites
229 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary goal of this clinical trial is to evaluate whether a community-based structured exercise therapy (CB-SET) intervention, which could be accessible and easily disseminated, adds benefit to peripheral artery disease (PAD) patients undergoing revascularization (REVASC) to improve their function and cardiovascular health.
CONDITIONS
Official Title
Community-based Exercise Following Revascularization for PAD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients receiving revascularization for aorto-iliac and/or femoral-popliteal disease in at least one limb
- Patients with focal and/or diffuse peripheral artery disease
- Patients with bilateral revascularization
- Ability to participate in an exercise program
You will not qualify if you...
- Lower limb amputations that affect treadmill walking
- Critical limb ischemia defined by rest pain or ulcers/gangrene on lower limbs
- Peripheral artery disease from non-atherosclerotic causes (e.g., fibromuscular dysplasia)
- Coronary artery bypass graft or major surgery within 6 months prior to screening
- Walking limited mainly by chronic lung disease, angina, or heart failure symptoms
- Myocardial infarction within 3 months prior to screening
- Transient ischemic attack or stroke within 3 months prior to screening
- Uncontrolled hypertension (systolic 65180 or diastolic 65100 mm Hg) during screening
- Use of pentoxifylline or cilostazol for claudication within 4 weeks prior to screening
- Poorly controlled diabetes (HbA1c >12%)
- Abnormal blood tests unsafe for exercise participation
- Inability to speak English
- Other significant unstable or confounding medical conditions as judged by the study team
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455
Actively Recruiting
Research Team
C
Courtney Farland-Johnson, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here